May-Thurner syndrome

May-Thurner syndrome (Cockett's syndrome, iliac vein compression syndrome, iliocaval compression syndrome) arises from the opression of the left iliac vein by the ongoing right iliac artery. Oppression occurs most often in the L5 area.

Pelvic vein compression was first described by Virchow, but May and Thurner determined the anatomical basis and variations of this condition already in 1957.

Aetiology and incidence
Chronic trauma to the venous wall, caused by the pulsation of the adjacent artery, leads to the accumulation of elastin and collagen in the wall and to local intimal proliferation, which results in the formation of fibrous synechiae (so-called spurs). There is a hemodynamically significant barrier to the outflow of venous blood from the limb and there is a gradual closure of the venous lumen and the development of deep venous thrombosis. In addition to mechanical damage to the vessel wall, most patients are diagnosed with hypercoagulability.

Although compression of the iliac communis sinistra is the most common form of May-Thurner syndrome, other variants have been described: The exact incidence of May-Thurner syndrome is unknown, but occurs in 18-49% of patients with left lower limb HRT (USA).
 * oppression vena iliaca communis sin. by the left internal iliac artery
 * oppression vena iliaca communis dx. by the right internal iliac artery
 * oppression vena cava inferior by the right common iliac artery

Symptomatology
Symptoms of May-Thurner syndrome fall under the manifestations of HRT and include:
 * unilateral edema and lower limb pain
 * claudication
 * changes resulting from post-thrombotic syndrome:
 * – skin hyperpigmentation
 * – varicose veins (varixes)
 * – chronic limb pain, feeling of pressure and heaviness
 * – phlebitis
 * – shin ulcers

A typical patient is a young woman between the ages of 20 and 40. year of life after long-term immobilisation or pregnancy.

However, the course of the disease is often asymptomatic. Kibbe et al. used CT scans to determine the occurrence of left common iliac vein oppression in an asymptomatic population. They found that 2/3 of all patients enrolled in the study had at least 25% compression. Based on this research, the authors concluded that oppression of the left iliac vein may be a normal anatomical finding.

Diagnostics
The diagnosis of the syndrome is based mainly on  clinical signs and anamnestic data obtained from the patient.

Imaging methods are other ancillary tests that significantly contribute to the correct diagnosis. Doppler ultrasonography captures deep vein thrombosis in the iliac vessels, but is unable to show vein compression. CT, NMR a MRV (magnetic resonance venography) give excellent results and allow you to view the site of stenosis, thrombus size, degree of obstruction and the topography of the environment. We indicate ascending phlebography as the gold standard of diagnosis only if we consider initiating interventional treatment.

Therapy
The treatment of symptomatic May-Thurner syndrome has seen a significant shift in recent years from open surgery to endovascular treatment.

The aim of the therapy is to remove the resulting thrombus and thus prevent post-thrombotic syndrome, and also to correct the oppression of the left pelvic vein, which is the basis of the disease. In the past, several treatments have been developed, such as the formation of a venous bypass by an autologous vein, the creation of a tissue loop to elevate the cruciate artery, retroposition of the iliac artery, and excision of the intraluminal thrombus, followed by venoplasty.

The basis of current therapy is either combination of surgical and endovascular approach or exclusively endovascular treatment.

The first step in therapy is thrombectomy. In particular, local thrombolysis by urokinase or t-PA is used by inserting a catheter into the site of obstruction, which reduces the risk of major bleeding, which is a complication of systemic thrombolysis. An alternative is mechanical thrombolysis. The second step is followed by angio plastic surgery with the insertion of a stent stent into the occlusion area to prevent possible reocclusion.

Patients after thrombectomy and venous stent implantation are routinely on anticoagulant therapy, for 6 months to minimize the occurrence of restenosis at the stent site.

Related articles

 * Chronická žilní nedostatečnost
 * Trombóza
 * Hluboká žilní trombóza
 * Vena iliaca communis
 * Arteria iliaca communis